Skin cancer drug sonidegib approved in United States The US Food and Drug Administration has approved sonidegib as a treatment for patients with locally advanced basal cell carcinoma.…
First PCSK9 inhibitors approved in Europe and United States The US Food and Drug Administration has approved alirocumab (Praluent), days after evolocumab (Repatha) became the first PCSK9 inhibitor to be approved in the world.…
Orthostatic hypotension drug midodrine to be launched Midodrine hydrochloride (Bramox) is due to be launched in the UK on 29 July 2015 after obtaining marketing authorisation from the medicines safety regulator, its manufacturer has announced.…
FDA approves brexpiprazole for schizophrenia and depression The US Food and Drug Administration has approved brexpiprazole for the treatment of adults with schizophrenia and as add-on therapy in patients with major depressive disorder.…
Innovation review seeks patients’ views on access to new medicines A new website is being launched on 15 July 2015 that will collate patients’ views on how access to innovative medicines and medical technology could be speeded up.…
FDA approves new heart failure combination therapy The US Food and Drug Administration has approved a new drug for heart failure that has “overwhelming benefit” for patients, according to the researchers who trialled the medicine.…
Cystic fibrosis therapy approved by US Food and Drug Administration A combination therapy of two drugs that target the most common genetic mutation responsible for cystic fibrosis has been given a licence in the United States.…
Nivolumab granted positive scientific opinion under UK early access scheme Nivolumab, a new lung cancer drug, has been granted a positive scientific opinion by the UK medicines safety regulator under the Early Access to Medicines Scheme (EAMS).…
Panobinostat set for approval in Europe as multiple myeloma treatment The multiple myeloma drug panobinostat has received a positive opinion from the European Medicines Agency for the treatment of relapsed or refractory disease.…
Cangrelor approved for use in the United StatesCangrelor has been approved for use in adult patients undergoing percutaneous coronary intervention in the United States, following a decision by the US Food and Drug Administration.…